Pulse Biosciences Cash Flow Statement (2020-2025) | PLSE

Cash Flow Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -14.28M-15.42M-17.27M-14.00M-18.04M-9.20M-9.80M-9.91M-10.57M-11.93M-10.14M-11.38M-12.68M-19.39M-16.80M-19.17M-19.37M
Depreciation and Depletion 0.10M0.10M0.10M0.12M0.11M0.10M0.10M0.15M0.20M0.10M0.20M0.18M0.14M0.10M0.10M0.14M0.13M0.10M0.10M0.11M0.12M0.10M0.10M
Share-based Compensation 2.63M2.41M2.65M2.39M6.96M2.45M1.58M3.61M2.01M1.71M0.72M0.75M0.90M1.14M1.80M3.34M1.76M2.05M2.98M6.79M5.68M5.19M5.62M
Gains from Investment Securities 0.01M-0.13M-0.01M5.48M0.23M5.56M5.61M5.71M5.61M6.89M7.90M11.60M12.33M0.83M0.00M13.51M
Asset Writedowns and Impairment 1.11M
Non-cash Items 2.30M2.47M2.52M9.60M2.91M3.04M3.15M15.80M3.67M3.47M3.57M3.48M3.43M3.59M3.65M3.83M4.02M4.14M4.18M4.53M4.75M4.99M4.81M
Cash from Operations -9.62M-7.94M-8.55M-9.26M-11.69M-16.37M-13.35M-12.69M-15.59M-12.82M-10.63M-7.96M-6.57M-9.20M-10.49M-6.78M-9.78M-8.39M-9.02M-9.14M-13.52M-12.81M-13.04M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.17M0.27M0.23M-0.00M0.17M0.39M0.29M
Depreciation & Amortization (CF) 0.10M0.10M0.10M0.12M0.11M0.10M0.10M0.15M0.20M0.10M0.20M0.18M0.14M0.10M0.10M0.14M0.13M0.10M0.10M0.11M0.12M0.10M0.10M
Change in Working Capital
Change in Receivables -0.05M0.03M0.10M-0.01M-0.04M-0.01M-0.00M-0.01M0.00M-0.11M-0.01M0.01M0.01M-0.01M-0.00M-0.04M0.01M0.01M0.00M
Change in Inventory 1.14M1.56M1.59M1.54M1.66M0.38M0.25M0.36M0.03M0.02M0.01M
Change in Account Payables -0.75M-0.01M0.16M0.33M0.43M0.61M-0.07M0.18M0.61M-1.54M0.04M-0.41M0.59M-0.38M-0.39M0.44M-0.12M-0.16M0.09M-0.01M0.71M0.33M0.27M
Change in Accured Expenses -0.42M0.82M0.96M1.48M0.29M-1.04M0.40M-0.58M0.21M0.08M-0.70M-1.39M0.50M-0.26M0.17M0.81M-1.55M0.91M0.64M3.21M-3.04M0.79M0.43M
Investing Activities
Capital Expenditures 0.17M-0.07M0.06M0.28M0.05M0.10M0.16M0.13M0.28M0.02M0.06M0.04M0.04M0.02M0.02M0.04M0.01M0.03M0.04M0.05M0.04M0.10M0.06M
Change in Acquisitions & Divestments 13.50M3.50M18.00M8.00M
Cash from Investing Activities 10.32M8.08M-22.57M14.21M7.95M-0.10M-0.16M-0.13M-0.28M-0.02M-0.06M-0.04M-0.04M-0.02M-0.02M-0.04M-0.01M-0.03M-0.04M-0.05M-0.04M-0.12M-0.06M
Financing Activities
Other financing activities 0.00M-0.06M0.06M
Debt Issuance and Repayment
Long-Term Debt Issuances 41.00M-39.27M0.21M
Long-Term Debt Repayments 0.66M0.44M
Change in Capital Stock
Shares Issued 0.26M29.50M-0.26M-0.06M4.89M8.40M8.35M0.37M14.59M-0.07M-0.03M0.29M-0.07M0.30M59.35M14.07M-0.01M0.02M
Misc.
Cash from Financing Activities 0.26M29.76M0.43M0.44M51.16M4.00M8.07M-0.55M-0.07M14.96M65.06M-0.02M-0.43M13.87M2.15M0.80M0.30M-0.27M61.90M48.20M14.81M1.97M
Change in Cash 0.96M29.90M-30.70M5.39M47.42M-12.46M-5.43M-13.38M-15.94M2.12M54.36M-8.02M-7.04M4.65M-8.36M-6.02M-9.48M-8.69M52.84M39.01M1.24M-12.93M-11.13M
Beginning Cash Balance 6.90M7.86M37.77M-5.39M12.46M59.88M47.44M57.74M28.61M12.68M14.80M69.16M61.14M54.10M58.75M50.39M44.38M34.88M26.20M79.03M118.04M119.28M106.35M
Free Cash Flow -9.79M-7.87M-8.61M-9.53M-11.74M-16.46M-13.51M-12.83M-15.87M-12.84M-10.69M-8.01M-6.61M-9.22M-10.51M-6.83M-9.79M-8.42M-9.06M-9.20M-13.57M-12.91M-13.10M
Net Cash Flow 0.96M29.90M-30.70M5.39M47.42M-12.46M-5.43M-13.38M-15.94M2.12M54.36M-8.02M-7.04M4.65M-8.36M-6.02M-9.48M-8.69M52.84M39.01M1.24M-12.93M-11.13M